POLYMYXIN for Covid-19 pneumonia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where POLYMYXIN was used for Covid-19 pneumonia.
Most Reported Side Effects for POLYMYXIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug hypersensitivity | 19 | 20.2% | 0 | 1 |
| Drug ineffective | 15 | 16.0% | 7 | 3 |
| Off label use | 12 | 12.8% | 3 | 6 |
| Myasthenia gravis crisis | 8 | 8.5% | 0 | 6 |
| Condition aggravated | 7 | 7.5% | 0 | 1 |
| Acute kidney injury | 6 | 6.4% | 2 | 0 |
| Erythema | 6 | 6.4% | 0 | 4 |
| Pyrexia | 5 | 5.3% | 1 | 4 |
Other Indications for POLYMYXIN
Product used for unknown indication (19)
Anti-infective therapy (6)
Acinetobacter infection (5)
Pneumonia (5)
Other Drugs Used for Covid-19 pneumonia
TOCILIZUMAB (1,583)
HYDROXYCHLOROQUINE (1,421)
REMDESIVIR (1,401)
DEXAMETHASONE (1,184)
LOPINAVIR\RITONAVIR (727)
AZITHROMYCIN ANHYDROUS (645)
CEFTRIAXONE (579)
METHYLPREDNISOLONE (450)
AZITHROMYCIN (408)
BARICITINIB (161)